Drugmakers See Bid to Defeat Class Action Fairness Act

, The National Law Journal

   | 0 Comments

Two pharmaceutical drug manufacturers told a federal en banc appeals panel on Thursday that plaintiffs were trying to circumvent the U.S. Class Action Fairness Act, which requires that “mass actions” be tried in federal court, by coordinating dozens of cases in California state court.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202660176498

Thank you!

This article's comments will be reviewed.